Eli Lilly LLY
NYSE LLY
$1,354.49 -10.24 (-0.75%)
At close: Nov 6, 2026 · 4:00 PM EST

Eli Lilly (LLY) Return on Invested Capital [ROIC] (2010 - 2026)

Updated

Eli Lilly's Return on Invested Capital [ROIC] came in at 38.16% for Q3 2026, up 4.48 percentage points from 33.68% a year earlier and up 0.99 percentage points from the prior quarter.

Analysis

Eli Lilly (LLY) Return on Invested Capital [ROIC] (2010 - 2026) Analysis & Trends

For FY2025, Eli Lilly's Return on Invested Capital [ROIC] was 40.07%, up 7.90 percentage points from FY2024.

  • Return on Invested Capital [ROIC] carries a five-year change of +11.14 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Invested Capital [ROIC] was 32.17% in FY2024 (+6.18 pp), 25.99% in FY2023 (-1.80 pp), 27.79% in FY2022 (+0.37 pp) and 27.42% in FY2021 (-1.51 pp).
  • The Q3 2026 figure represents the highest quarterly Return on Invested Capital [ROIC] in data going back to Q1 2010.
  • Year-over-year, Return on Invested Capital [ROIC] has increased for 11 consecutive quarters, with an average year-over-year change of +5.91 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Invested Capital [ROIC] over five years came in Q1 2026 (a gain of 7.76 percentage points), and the weakest in Q2 2023 (a drop of 8.00 percentage points).
  • Business Quant data shows LLY's Return on Invested Capital [ROIC] at 37.16% (Q2 2026), 37.83% (Q1 2026) and 34.61% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 38.16%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.57%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 24.28%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 2.88%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 24.11%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 15.60%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -6.11%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 12.34%
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 38.16%
Jun 30, 2026 37.16%
Mar 31, 2026 37.83%
Dec 31, 2025 34.61%
Sep 30, 2025 33.68%
Jun 30, 2025 31.95%
Mar 31, 2025 30.06%
Dec 31, 2024 28.95%
Sep 30, 2024 25.97%
Jun 30, 2024 25.86%
Mar 31, 2024 24.35%
Dec 31, 2023 24.27%
Sep 30, 2023 24.65%
Jun 30, 2023 22.66%
Mar 31, 2023 22.36%
Dec 31, 2022 27.79%
Sep 30, 2022 29.73%
Jun 30, 2022 30.67%
Mar 31, 2022 29.51%
Dec 31, 2021 26.02%
API Access

Eli Lilly Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=LLY&period=max&api_key=YOUR_API_KEY